Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
We report the case of a 50-year-old woman with severe palmoplantar psoriasis who developed alopecia areata (AA) 2 months after initiating treatment with tildrakizumab (100 mg subcutaneously). The patient had no personal or familial history of autoimmune disorders, and the diagnosis of AA was confir...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
PAGEPress Publications
2026-01-01
|
| سلاسل: | Dermatology Reports |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://journals.pagepress.net/dr/article/view/10240 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|